4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-024640
Director bought 1,000 shares at $10.09 ($10,090)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Katz Ilan Director | 2021-10-01 | Purchase | +1,000 | $10.09 | $10,090 | 1,000 | D: show line 1 in the form |
| Open-market purchases · 1,000 sh · avg $10.09 · $10,090 | |||||||
Loading xslF345X03/ownership.xml…